HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzyme pathology and the histologic categorization of human lung tumors: the continuum of quantitative biochemical indices of neoplasticity.

Abstract
The purpose of the present enzymic and histologic analysis of pulmonary samples from 39 subjects was to discern a common, meaningful pattern which may underlie the biochemical heterogeneity of lung neoplasms. The distribution among the different tumors of thymidine kinase, uridine kinase, phosphoserine phosphatase, hexokinase and adenylate kinase was found to correlate with each other. By averaging their standardized units (normal lung = 0) an enzymic index of neoplasticity was calculated for each tumor and used (in increasing order) to rank all 39. The index, showing a significant positive correlation with mitotic frequency, encompassed a continuous 100-fold range. Poorly differentiated carcinomas ranked high while neoplasms with better differentiation and prognosis placed in the lower half of the range. The results indicate that enzymes showing coordinated variations over a broad spectrum of tumors could contribute objective criteria to the rating of any individual tumor against a continuous, quantitative scale of neoplasticity.
AuthorsO Greengard, J F Head, S L Goldberg, P A Kirschner
JournalCancer (Cancer) Vol. 49 Issue 3 Pg. 460-7 (Feb 01 1982) ISSN: 0008-543X [Print] United States
PMID6277448 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Phosphotransferases
  • Alkaline Phosphatase
  • Fructose-Bisphosphate Aldolase
Topics
  • Adenocarcinoma (enzymology)
  • Alkaline Phosphatase (metabolism)
  • Carcinoma, Small Cell (enzymology)
  • Carcinoma, Squamous Cell (enzymology)
  • Fructose-Bisphosphate Aldolase (metabolism)
  • Humans
  • Lung Neoplasms (enzymology)
  • Phosphotransferases (metabolism)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: